Endothelin-1 induces contraction via a Syk-mediated p38 mitogen-activated protein kinase pathway in rat aortic smooth muscle

Journal of Pharmacological Sciences

Volumn 103, Issue 4, 2007, Pages 427-433

  Hwan, Myung Lee ^a   Won, Kyung Jong ^a   Kim, Junghwan ^b   Park, Hyo Jun ^a   Hyo, Jin Kim ^a   Hui, Yul Roh ^a   So, Hee Lee ^a   Lee, Chang Kwon ^a   Kim, Bokyung ^a  

^a Konkuk University   (South Korea)

^b Yongin University   (South Korea)

Author keywords

Contraction; Endothelin 1; p38 mitogen activated protein kinase (MAPK); Rat aortic smooth muscle cell (RASMC); Spleen tyrosine kinase (Syk)

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ENDOTHELIN 1; HEAT SHOCK PROTEIN 27; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PICEATANNOL; PROTEIN KINASE SYK;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA MEDIA; AORTA STRIP; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IMMUNOBLOTTING; MALE; MUSCLE CONTRACTION; NONHUMAN; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER;

EID: 34247384270     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0070039     Document Type: Article

References (37)

1. Lee CK, Park HJ, So HH, Kim HJ, Lee KS, Choi WS, et al. Proteomic profiling and identification of cofilin responding to oxidative stress in vascular smooth muscle. Proteomics. 2006;6:6455-6475.
2. Yanagisawa M, Masaki T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci. 1989;10:374-378.
3. Pang DC, Johns A, Patterson K, Botelho LH, Rubanyi GM. Endothelin-1 stimulates phosphatidylinositol hydrolysis and calcium uptake in isolated canine coronary arteries. J Cardiovasc Pharmacol. 1989;13:S75-S79.
4. Pollock DM, Keith TL, Highsmith RF. Endothelin receptors and calcium signaling. FASEB J. 1995;9:1196-1204.
5. Kamm KE, Stull JT. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol. 1985;25:593-620.
6. Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, et al. Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev. 1997;49:157-230.
7. Yoshida M, Suzuki A, Itoh T. Mechanisms of vasoconstriction induced by endothelin-1 in smooth muscle of rabbit mesenteric artery. J Physiol. 1994;477:253-265.
8. Hori M, Sato K, Sakata K, Ozaki H, Takano-Ohmuro H, Tsuchiya T, et al. Receptor agonists induce myosin phosphorylation-dependent and phosphorylation-independent contractions in vascular smooth muscle. J Pharmacol Exp Ther. 1992;261:506-512.
9. Kwon S, Lee WJ, Fang LH, Kim B, Ahn HY. Mitogen-activated protein kinases partially regulate endothelin-1-induced contractions through a myosin light chain phosphorylation-independent pathway. J Vet Med Sci. 2003;65:225-230.
10. 2+ sensitivity of contractile elements in rat myometrium. Biochem Biophys Res Commun. 2003;311:972-978.
11. Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci. 2001;22:32-39.
12. 2+ sensitivity in rabbit smooth muscle. J Physiol. 1995;487:283-289.
13. Lee YH, Kim I, Laporte R, Walsh MP, Morgan KG. Isozyme-specific inhibitors of protein kinase C translocation: effects on contractility single permeabilized vascular muscle cells of the ferret. J Physiol. 1999;517:709-720.
14. Kim B, Kim YS, Ahn J, Kim J, Cho SI, Won KJ, et al. Conventional-type protein kinase C contributes to phorbol ester-induced inhibition of rat myometrial tension. Br J Pharmacol. 2003;139:408-414.
15. Pollock DM, Keith TL, Highsmith RF. Endothelin receptors and calcium signaling. FASEB J. 1995;9:1196-1204.
16. D'Angelo G, Adam LP. Inhibition of ERK attenuates force development by lowering myosin light chain phosphorylation. Am J Physiol. 2002;282:H602-H610.
17. i sensitization pathways. Hypertension. 2002;39:543-549.
18. 2+ channels and vasoconstriction. Biochem Pharmacol. 2004;68:215-221.
19. Zubkov A, Miao L, Zhang J. Signal transduction of ET-1 in contraction of cerebral arteries. J Cardiovasc Pharmacol. 2004;44:S24-S26.
20. Dessy C, Kim I, Sougnez CL, Laporte R, Morgan KG. A role for MAP kinase in differentiated smooth muscle contraction evoked by alpha-adrenoceptor stimulation. Am J Physiol. 1998;275:C1081-C1086.
21. Kim B, Kim J, Bae YM, Cho SI, Kwon SC, Jung JY, et al. p38 Mitogen-activated protein kinase contributes to the diminished aortic contraction by endothelin-1 in DOCA-salt hypertensive rats. Hypertension. 2004;43:1086-1091.
22. Kim J, Lee YR, Lee CH, Choi WH, Lee CK, Kim J, et al. Mitogen-activated protein kinase contributes to elevated basal tone in aortic smooth muscle from hypertensive rats. Eur J Pharmacol. 2005;514:209-215.
23. Berton G, Mocsai A, Lowell CA. Src and Syk kinases: key regulators of phagocytic cell activation. Trends Immunol. 2005;26:208-214.
24. Lee CK, Lee HM, Kim HJ, Park HJ, Won KJ, Roh HY, et al. Syk contributes to PDGF-BB-mediated migration of rat aortic smooth muscle cells via MAPK pathways. Cardiovas Res. 2007;74:159-168.
25. Yamboliev IA, Hedges JC, Mutnick JL, Adam LP, Gerthoffer WT. Evidence for modulation of smooth muscle force by the p38 MAP kinase/HSP27 pathway. Am J Physiol. 2000;278:H1899-H1907.
26. Yanagi S, Inatome R, Takano T, Yamamura H. Syk expression and novel function in a wide variety of tissues. Biochem Biophys Res Commun. 2001;288:495-498.
27. Inatome R, Yanagi S, Takano T, Yamamura H. A critical role for Syk in endothelial cell proliferation and migration. Biochem Biophys Res Commun. 2001;286:195-199.
28. Seow CJ, Chue SC, Fred WS. Piceatannol, a Syk-selective tyrosine kinase inhibitor, attenuated antigen challenge of guinea pig airways in vitro. Eur J Pharmacol. 2002;443:189-196.
29. Stenton GR, Ulanova M, Dery RE, Merani S, Kim MK, Gilchrist M, et al. Inhibition of allergic inflammation in the airways using aerosolized antisense to Syk kinase. J Immunol. 2002;168:1028-1036.
30. Kwon S, Fang LH, Kim B, Ha TS, Lee SJ, Ahn HY. p38 Mitogen-activated protein kinase regulates vasoconstriction in spontaneously hypertensive rats. J Pharmacol Sci. 2004;95:267-272.
31. Huot J, Houle F, Marceau F, Landry J. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res. 1997;80:383-392.
32. Fegley AJ, Tanski WJ, Roztocil E, Davies MG. Sphingosine-1-phosphate stimulates smooth muscle cell migration through Gαi- and PI3-kinase-dependent p38 (MAPK) activation. J Surg Res. 2003;113:32-41.
33. Kozawa O, Tanabe K, Ito H, Matsuno H, Niwa M, Kato K, et al. Sphingosine 1-phosphate regulates heat shock protein 27 induction by a p38 MAP kinase-dependent mechanism in aortic smooth muscle cells. Exp Cell Res. 1999;250:376-380.
34. Hedges JC, Dechert MA, Yamboliev IA, Martin JL, Hickey E, Weber LA, et al. A role for p38 MAPK/HSP27 pathway in smooth muscle cell migration. J Biol Chem. 1999;274:24211-24219.
35. Lee YR, Lee CK, Park HJ, Kim HJ, Kim J, Kim J, et al. c-Jun N-terminal kinase contributes to norepinephrine-induced contraction through phosphorylation of caldesmon in rat aortic smooth muscle. J Pharmacol Sci. 2006;100:119-125.
36. Wang CL. Caldesmon and smooth muscle regulation. Cell Biochem Biophys. 2001;35:275-288.
37. Tasaki K, Hori M, Ozaki H, Karaki H, Wakabayashi I. Mechanism of human urotensin II-induced contraction in rat aorta. J Pharmacol Sci. 2004;94:376-383.